Abbott Laboratories (ABT)
USD 111.93
(-1.2%)
USD 111.93
(-1.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 6.47 Billion USD | -22.53% |
| 2022 | 8.36 Billion USD | -0.75% |
| 2021 | 8.42 Billion USD | 57.27% |
| 2020 | 5.35 Billion USD | 18.2% |
| 2019 | 4.53 Billion USD | 24.16% |
| 2018 | 3.65 Billion USD | 111.47% |
| 2017 | 1.72 Billion USD | -45.81% |
| 2016 | 3.18 Billion USD | 11.09% |
| 2015 | 2.86 Billion USD | 10.31% |
| 2014 | 2.59 Billion USD | -1.14% |
| 2013 | 2.62 Billion USD | -67.48% |
| 2012 | 8.08 Billion USD | 40.56% |
| 2011 | 5.75 Billion USD | -5.52% |
| 2010 | 6.08 Billion USD | -2.37% |
| 2009 | 6.23 Billion USD | 9.52% |
| 2008 | 5.69 Billion USD | 24.36% |
| 2007 | 4.57 Billion USD | 124.19% |
| 2006 | 2.04 Billion USD | -53.18% |
| 2005 | 4.36 Billion USD | 11.9% |
| 2004 | 3.89 Billion USD | 17.33% |
| 2003 | 3.32 Billion USD | -5.88% |
| 2002 | 3.53 Billion USD | 86.38% |
| 2001 | 1.89 Billion USD | -44.3% |
| 2000 | 3.4 Billion USD | 7.98% |
| 1999 | 3.14 Billion USD | 1.01% |
| 1998 | 3.11 Billion USD | 9.38% |
| 1997 | 2.85 Billion USD | 8.92% |
| 1996 | 2.61 Billion USD | 9.83% |
| 1995 | 2.38 Billion USD | 11.13% |
| 1994 | 2.14 Billion USD | 11.45% |
| 1993 | 1.92 Billion USD | 26.08% |
| 1992 | 1.52 Billion USD | -1.99% |
| 1991 | 1.55 Billion USD | 10.73% |
| 1990 | 1.4 Billion USD | 15.14% |
| 1989 | 1.22 Billion USD | 10.82% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.72 Billion USD | 18.83% |
| 2024 Q1 | 1.45 Billion USD | -22.21% |
| 2024 Q3 | 1.85 Billion USD | 7.89% |
| 2023 Q2 | 1.66 Billion USD | -0.89% |
| 2023 Q4 | 1.86 Billion USD | 5.37% |
| 2023 Q3 | 1.76 Billion USD | 6.37% |
| 2023 FY | 6.47 Billion USD | -22.53% |
| 2023 Q1 | 1.67 Billion USD | 28.68% |
| 2022 FY | 8.36 Billion USD | -0.75% |
| 2022 Q1 | 2.91 Billion USD | 22.46% |
| 2022 Q2 | 2.37 Billion USD | -18.41% |
| 2022 Q3 | 1.77 Billion USD | -25.51% |
| 2022 Q4 | 1.3 Billion USD | -26.33% |
| 2021 Q4 | 2.37 Billion USD | -6.6% |
| 2021 FY | 8.42 Billion USD | 57.27% |
| 2021 Q2 | 1.39 Billion USD | -34.0% |
| 2021 Q1 | 2.1 Billion USD | -13.28% |
| 2021 Q3 | 2.54 Billion USD | 82.9% |
| 2020 Q3 | 1.49 Billion USD | 122.47% |
| 2020 Q1 | 758 Million USD | -45.43% |
| 2020 FY | 5.35 Billion USD | 18.2% |
| 2020 Q4 | 2.43 Billion USD | 62.68% |
| 2020 Q2 | 672 Million USD | -11.35% |
| 2019 Q2 | 1.2 Billion USD | 63.19% |
| 2019 Q4 | 1.38 Billion USD | 15.94% |
| 2019 FY | 4.53 Billion USD | 24.16% |
| 2019 Q1 | 739 Million USD | -36.57% |
| 2019 Q3 | 1.19 Billion USD | -0.66% |
| 2018 FY | 3.65 Billion USD | 111.47% |
| 2018 Q1 | 608 Million USD | -12.01% |
| 2018 Q2 | 882 Million USD | 45.07% |
| 2018 Q4 | 1.16 Billion USD | 17.09% |
| 2018 Q3 | 995 Million USD | 12.81% |
| 2017 Q3 | 810 Million USD | 89.7% |
| 2017 Q1 | -202 Million USD | -121.31% |
| 2017 Q2 | 427 Million USD | 311.39% |
| 2017 Q4 | 691 Million USD | -14.69% |
| 2017 FY | 1.72 Billion USD | -45.81% |
| 2016 Q1 | 524 Million USD | -35.71% |
| 2016 FY | 3.18 Billion USD | 11.09% |
| 2016 Q3 | 897 Million USD | 9.93% |
| 2016 Q4 | 948 Million USD | 5.69% |
| 2016 Q2 | 816 Million USD | 55.73% |
| 2015 FY | 2.86 Billion USD | 10.31% |
| 2015 Q4 | 815 Million USD | 14.31% |
| 2015 Q2 | 729 Million USD | 19.51% |
| 2015 Q3 | 713 Million USD | -2.19% |
| 2015 Q1 | 610 Million USD | -26.42% |
| 2014 Q2 | 761 Million USD | 68.74% |
| 2014 FY | 2.59 Billion USD | -1.14% |
| 2014 Q3 | 731 Million USD | -3.94% |
| 2014 Q1 | 451 Million USD | -40.42% |
| 2014 Q4 | 829 Million USD | 13.41% |
| 2013 Q1 | 615 Million USD | -74.54% |
| 2013 FY | 2.62 Billion USD | -67.48% |
| 2013 Q4 | 757 Million USD | 20.16% |
| 2013 Q3 | 630 Million USD | 0.48% |
| 2013 Q2 | 627 Million USD | 1.95% |
| 2012 Q4 | 2.41 Billion USD | 21.43% |
| 2012 FY | 8.08 Billion USD | 40.56% |
| 2012 Q1 | 1.57 Billion USD | -24.32% |
| 2012 Q2 | 2.1 Billion USD | 33.5% |
| 2012 Q3 | 1.98 Billion USD | -5.47% |
| 2011 Q2 | 1.77 Billion USD | 36.28% |
| 2011 Q3 | 595 Million USD | -66.44% |
| 2011 Q4 | 2.08 Billion USD | 249.99% |
| 2011 FY | 5.75 Billion USD | -5.52% |
| 2011 Q1 | 1.3 Billion USD | -28.91% |
| 2010 Q3 | 1.18 Billion USD | -26.46% |
| 2010 FY | 6.08 Billion USD | -2.37% |
| 2010 Q1 | 1.47 Billion USD | -21.08% |
| 2010 Q2 | 1.6 Billion USD | 9.18% |
| 2010 Q4 | 1.82 Billion USD | 54.95% |
| 2009 FY | 6.23 Billion USD | 9.52% |
| 2009 Q3 | 1.64 Billion USD | -1.86% |
| 2009 Q4 | 1.86 Billion USD | 13.65% |
| 2009 Q1 | 1.06 Billion USD | -39.14% |
| 2009 Q2 | 1.67 Billion USD | 57.53% |
| 2008 Q3 | 1.39 Billion USD | -0.72% |
| 2008 FY | 5.69 Billion USD | 24.36% |
| 2008 Q4 | 1.74 Billion USD | 24.8% |
| 2008 Q2 | 1.4 Billion USD | 22.54% |
| 2008 Q1 | 1.14 Billion USD | -24.38% |
| 2007 Q2 | 1.18 Billion USD | 35.09% |
| 2007 Q1 | 878.18 Million USD | 445.85% |
| 2007 Q4 | 1.51 Billion USD | 63.83% |
| 2007 FY | 4.57 Billion USD | 124.19% |
| 2007 Q3 | 926.55 Million USD | -21.9% |
| 2006 Q4 | -253.92 Million USD | -136.84% |
| 2006 Q3 | 689.16 Million USD | 26.97% |
| 2006 FY | 2.04 Billion USD | -53.18% |
| 2006 Q2 | 542.77 Million USD | -49.0% |
| 2006 Q1 | 1.06 Billion USD | -18.19% |
| 2005 Q3 | 830.68 Million USD | -24.13% |
| 2005 Q1 | 1.13 Billion USD | 0.59% |
| 2005 FY | 4.36 Billion USD | 11.9% |
| 2005 Q4 | 1.3 Billion USD | 56.59% |
| 2005 Q2 | 1.09 Billion USD | -3.61% |
| 2004 Q3 | 1.02 Billion USD | 28.39% |
| 2004 Q1 | 1.03 Billion USD | -6.66% |
| 2004 Q2 | 796.45 Million USD | -22.84% |
| 2004 Q4 | 1.12 Billion USD | 10.43% |
| 2004 FY | 3.89 Billion USD | 17.33% |
| 2003 Q1 | 980.49 Million USD | 10.32% |
| 2003 Q2 | 325.14 Million USD | -66.84% |
| 2003 Q3 | 911.03 Million USD | 180.2% |
| 2003 Q4 | 1.1 Billion USD | 21.38% |
| 2003 FY | 3.32 Billion USD | -5.88% |
| 2002 Q1 | 1.04 Billion USD | 46.21% |
| 2002 Q4 | 888.79 Million USD | -2.69% |
| 2002 FY | 3.53 Billion USD | 86.38% |
| 2002 Q3 | 913.39 Million USD | 33.71% |
| 2002 Q2 | 683.09 Million USD | -34.62% |
| 2001 Q2 | 598.51 Million USD | 465.55% |
| 2001 Q3 | 744.63 Million USD | 24.41% |
| 2001 Q4 | 714.61 Million USD | -4.03% |
| 2001 FY | 1.89 Billion USD | -44.3% |
| 2001 Q1 | -163.73 Million USD | -117.74% |
| 2000 Q1 | 851.36 Million USD | 1.24% |
| 2000 Q2 | 841.56 Million USD | -1.15% |
| 2000 Q3 | 784.72 Million USD | -6.75% |
| 2000 Q4 | 922.92 Million USD | 17.61% |
| 2000 FY | 3.4 Billion USD | 7.98% |
| 1999 Q2 | 829.55 Million USD | -8.11% |
| 1999 Q4 | 840.92 Million USD | 45.96% |
| 1999 Q1 | 902.75 Million USD | 8.52% |
| 1999 FY | 3.14 Billion USD | 1.01% |
| 1999 Q3 | 576.14 Million USD | -30.55% |
| 1998 Q4 | 831.86 Million USD | 18.25% |
| 1998 FY | 3.11 Billion USD | 9.38% |
| 1998 Q3 | 703.47 Million USD | -9.77% |
| 1998 Q2 | 779.68 Million USD | -2.89% |
| 1998 Q1 | 802.88 Million USD | 2.81% |
| 1997 Q3 | 621.48 Million USD | -12.74% |
| 1997 Q4 | 780.91 Million USD | 25.65% |
| 1997 FY | 2.85 Billion USD | 8.92% |
| 1997 Q1 | 735.81 Million USD | 2.8% |
| 1997 Q2 | 712.21 Million USD | -3.21% |
| 1996 Q3 | 574.7 Million USD | -11.8% |
| 1996 FY | 2.61 Billion USD | 9.83% |
| 1996 Q1 | 674.99 Million USD | 2.92% |
| 1996 Q2 | 651.58 Million USD | -3.47% |
| 1996 Q4 | 715.77 Million USD | 24.55% |
| 1995 FY | 2.38 Billion USD | 11.13% |
| 1995 Q4 | 655.85 Million USD | 20.8% |
| 1995 Q2 | 594.65 Million USD | 0.88% |
| 1995 Q1 | 589.47 Million USD | -0.04% |
| 1995 Q3 | 542.91 Million USD | -8.7% |
| 1994 Q2 | 543.48 Million USD | 3.13% |
| 1994 Q3 | 484.02 Million USD | -10.94% |
| 1994 Q4 | 589.69 Million USD | 21.83% |
| 1994 FY | 2.14 Billion USD | 11.45% |
| 1994 Q1 | 526.99 Million USD | -14.18% |
| 1993 Q4 | 614.06 Million USD | 37.93% |
| 1993 FY | 1.92 Billion USD | 26.08% |
| 1993 Q2 | 419.2 Million USD | -5.9% |
| 1993 Q1 | 445.5 Million USD | -4.91% |
| 1993 Q3 | 445.2 Million USD | 6.2% |
| 1992 Q3 | 443.2 Million USD | 120.28% |
| 1992 Q2 | 201.2 Million USD | -51.31% |
| 1992 Q4 | 468.5 Million USD | 5.71% |
| 1992 Q1 | 413.2 Million USD | -10.45% |
| 1992 FY | 1.52 Billion USD | -1.99% |
| 1991 Q4 | 461.4 Million USD | 30.86% |
| 1991 FY | 1.55 Billion USD | 10.73% |
| 1991 Q2 | 372 Million USD | 0.27% |
| 1991 Q3 | 352.6 Million USD | -5.22% |
| 1991 Q1 | 371 Million USD | -7.92% |
| 1990 Q4 | 402.9 Million USD | 24.89% |
| 1990 FY | 1.4 Billion USD | 15.14% |
| 1990 Q3 | 322.6 Million USD | -8.53% |
| 1990 Q2 | 352.7 Million USD | 7.56% |
| 1990 Q1 | 327.9 Million USD | 112.13% |
| 1989 Q3 | 1.31 Billion USD | -0.62% |
| 1989 Q1 | 1.29 Billion USD | 151.23% |
| 1989 Q4 | -2.7 Billion USD | -306.3% |
| 1989 Q2 | 1.31 Billion USD | 1.78% |
| 1989 FY | 1.22 Billion USD | 10.82% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Allurion Technologies Inc. | -78.07 Million USD | 8396.831% |
| Artivion, Inc. | 5.74 Million USD | -112717.834% |
| Avanos Medical, Inc. | 4.2 Million USD | -154138.095% |
| Butterfly Network, Inc. | -145.61 Million USD | 4548.87% |
| Butterfly Network, Inc. | -145.61 Million USD | 4548.87% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | -1587.876% |
| Boston Scientific Corporation | 2.34 Billion USD | -176.483% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 42768.95% |
| CONMED Corporation | 130.78 Million USD | -4853.13% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | -322.267% |
| Paragon 28, Inc. | -37.3 Million USD | 17463.103% |
| Glaukos Corporation | -128.7 Million USD | 5133.411% |
| Globus Medical, Inc. | 133.14 Million USD | -4765.482% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 16186.017% |
| Integer Holdings Corporation | 167.33 Million USD | -3771.392% |
| Medtronic plc | 5.14 Billion USD | -25.933% |
| Nevro Corp. | -99.3 Million USD | 6623.14% |
| Owlet, Inc. | -28.63 Million USD | 22725.035% |
| Penumbra, Inc. | 73.55 Million USD | -8707.494% |
| Vicarious Surgical Inc. | -80.66 Million USD | 8130.645% |
| Smith & Nephew plc | 425 Million USD | -1424.235% |
| Sonendo, Inc. | -57.74 Million USD | 11318.676% |
| STERIS plc | 836.11 Million USD | -674.771% |
| Stryker Corporation | 3.88 Billion USD | -66.615% |
| Vapotherm, Inc. | -39.08 Million USD | 16676.254% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | -407.005% |